The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hahn, A. B.
Right arrow Articles by Soloski, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hahn, A. B.
Right arrow Articles by Soloski, M. J.

The Journal of Immunology, Vol 143, Issue 2 407-413, Copyright © 1989 by American Association of Immunologists


ARTICLES

Anti-Qa-2-induced T cell activation. The parameters of activation, the definition of mitogenic and nonmitogenic antibodies, and the differential effects on CD4+ vs CD8+ T cells

AB Hahn and MJ Soloski
Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205.

The MHC Ag Qa-2 is a glycolipid anchored class I molecule expressed at high levels on all peripheral T lymphocytes. In this study we found that anti-Qa-2 antibodies could stimulate the proliferation of murine T cells in vitro. Anti-Qa-2-induced proliferation required secondary cross-linking with anti-Ig antibody and the presence of PMA. Only Qa-2+ strains could be induced to proliferate by anti-Qa-2 antibody, but under the conditions employed, anti-CD3 could induce proliferation in Qa-2+ and Qa-2-strains. Interestingly, only anti-Qa-2 reagents directed against the alpha 3 domain of the Qa-2 class I molecule were effective in inducing proliferation. Furthermore, unlike purified CD4+ cells, purified CD8+ cells were unable to be stimulated by the anti-Qa-2 antibodies. These results lead to the inclusion of Qa-2 in a group of physiologically relevant, glycolipid-anchored, cell-surface molecules, mobilization of which can generate signals that initiate the proliferation of T cells. Such molecules may play a secondary role in cellular activation after the primary engagement of the TCR.


This article has been cited by other articles:


Home page
J. Immunol.Home page
E. Y. Chiang, M. Henson, and I. Stroynowski
The Nonclassical Major Histocompatibility Complex Molecule Qa-2 Protects Tumor Cells from NK Cell- and Lymphokine-Activated Killer Cell-Mediated Cytolysis
J. Immunol., March 1, 2002; 168(5): 2200 - 2211.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
A. S. McElhinny and C. M. Warner
Cross-linking of Qa-2 protein, the Ped gene product, increases the cleavage rate of C57BL/6 preimplantation mouse embryos
Mol. Hum. Reprod., June 1, 2000; 6(6): 517 - 522.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Gui, D. L. Wiest, J. Li, D. Kappes, R. R. Hardy, and K. Hayakawa
Peripheral CD4+ T Cell Maturation Recognized by Increased Expression of Thy-1/CD90 Bearing the 6C10 Carbohydrate Epitope
J. Immunol., November 1, 1999; 163(9): 4796 - 4804.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
M. D. Marmor, M. F. Bachmann, P. S. Ohashi, T. R. Malek, and M. Julius
Immobilization of glycosylphosphatidylinositol-anchored proteins inhibits T cell growth but not function
Int. Immunol., September 1, 1999; 11(9): 1381 - 1393.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. M. Stulnig, M. Berger, T. Sigmund, H. Stockinger, V. Horejsi, and W. Waldhausl
Signal Transduction via Glycosyl Phosphatidylinositol-anchored Proteins in T Cells Is Inhibited by Lowering Cellular Cholesterol
J. Biol. Chem., August 1, 1997; 272(31): 19242 - 19247.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1989 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1989 by The American Association of Immunologists, Inc. All rights reserved.